VSL#3: all 47 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative ColitisRecruitingNCT06609447Phase 4
- VSL#3® vs Placebo in the Treatment of Fatigue and Other Symptoms in Long Covid (DELong#3)RecruitingNCT05874089Not applicable
- Intervention on New Onset-T1D ChildrenRecruitingNCT05767450Not applicable
- Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to FibromyalgiaCompletedNCT04256785Not applicableResults posted
- Effect of VSL#3 on Bone Mineral Density in Postmenopausal WomenTerminatedNCT03165747Phase 2Results posted
- Probiotic (VSL #3) for Gulf War IllnessTerminatedNCT02011542Phase 2/3Results posted
- Safety of VSL#3 in Adult AsthmaticsTerminatedNCT00852124Phase 1/2Results posted
- Probiotics and Hospital Outcome in the ElderlyCompletedNCT00794924Not applicableResults posted
- Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)CompletedNCT00630838Phase 2Results posted
- Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving ImmunotherapySuspendedNCT06508034Not applicable
- Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal and ZambiaStatus unknownNCT05608928Phase 2
- Impact of Probiotics on Oral Microbiota in Older Adults With DysphagiaCompletedNCT03682094Early Phase 1
- One Year Home Monitoring and Treatment of IBS PatientsStatus unknownNCT03586622Not applicable
- Modulation of Type 1 Diabetes Susceptibility Through the Use of ProbioticsCompletedNCT03423589Not applicable
- PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative ColitisTerminatedNCT03415711Not applicable
- Probiotics and the Gut Microbiome in Obese Hispanic YouthTerminatedNCT03115385Not applicable
- Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)CompletedNCT03092427Not applicable
- Probiotic (Visbiome) for Gulf War IllnessStatus unknownNCT03078530Phase 2/3
- Investigating the Effect of Dietary Supplement VSL#3 on Cognition and Mood in Healthy Older AdultsStatus unknownNCT01877967Not applicable
- Impact of Probiotic Preparation VSL#3 on Infants ColicsStatus unknownNCT01869426Phase 4
- The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel DiseaseActive, not recruitingNCT01765439Not applicable
- Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With CirrhosisCompletedNCT01686698Phase 4
- Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90°CompletedNCT01650025Not applicable
- Changes in Gastrointestinal Microbiota Using VSL#3 in Patients With IBS-DStatus unknownNCT01638208Phase 4
- Effects of Probiotic VSL#3 on Expression of Small Intestinal Renin-angiotensin SystemCompletedNCT01635192Early Phase 1
- A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's DiseaseStatus unknownNCT01632462Phase 4
- The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's DiseaseStatus unknownNCT01548014Phase 3
- Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation TherapyWithdrawnNCT01473290Phase 3
- Influence of Probiotic VSL#3 Administration on Metabolic and Immunological Profile of the Milk of Breastfeeding MothersCompletedNCT01367470Phase 4
- New E-Service for a Dietary Approach to the ElderlyCompletedNCT01179789Early Phase 1
- Secondary Prophylaxis of Hepatic Encephalopathy in CirrhosisStatus unknownNCT01178372Phase 4
- Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel SyndromeCompletedNCT01139736Phase 4
- Probiotics for Portal HypertensionStatus unknownNCT01134692Phase 3
- Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic PreparationCompletedNCT01110447Phase 2/3
- Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of LifeCompletedNCT01008293Phase 2/3
- Probiotics for the Prevention of Antibiotics Associated Diarrhoea and Clostridium Difficile Associated DiarrhoeaCompletedNCT00973908Phase 2/3
- Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative ColitisCompletedNCT00951548Not applicable
- Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's DiseaseCompletedNCT00944736Phase 3
- A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRECompletedNCT00933556Phase 2
- The Use of VSL#3 in Irritable Bowel Syndrome in ChildrenTerminatedNCT00932841Phase 1
- Evaluation of Probiotics in the Treatment of Portal HypertensionCompletedNCT00831337Not applicable
- Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel SyndromeCompletedNCT00786123Not applicable
- Probiotics for Eradication of Carbapenem Resistant Klebsiella PneumoniaStatus unknownNCT00722410Phase 1/2
- VSL#3 Treatment in Children With Crohn's DiseaseStatus unknownNCT00367705Phase 4
- Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBSTerminatedNCT00179582Not applicable
- VSL#3 Versus Placebo in Maintenance of Remission in Crohn's DiseaseCompletedNCT00114465Phase 4
- The Effect of a Probiotic on Hepatic SteatosisTerminatedNCT00099723Phase 1